Breaking Down the Data in Hyperkalemia

Slides:



Advertisements
Similar presentations
Volume 62, Issue 3, Pages (September 2002)
Advertisements

Chronic HCV Infection and CKD
Prior Trials of RAAS Inhibitors
SAVOR-TIMI 53 Summary SAVOR-TIMI 53: Primary End Point of CV Death, MI, Ischemic Stroke.
Emerging Concepts in Heart Failure
Current State of Hyperkalemia Management
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Chronic Hepatitis C Virus Infection
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Starting Strong: Initial Evaluation of the Patient With HCV
New and Emerging Management Options for Anemia in CKD
An Endocrinology Clinic in Dyslipidemia
PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Rate, HF Admissions, and Readmissions
New Therapies for Hyperkalemia Across the Continuum of Care
A CASE CHALLENGE IN HFrEF:
UNDERSTANDING RISK STRATIFICATION IN PAH:
At The Cutting Edge of Developments in the Management of Hyperkalemia
Updates Abound in Hyperkalemia Management
Updates on Outcomes for Novel T2D Therapies
PCP Perspectives Clinical Considerations in Hyperkalemia
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Managing Hereditary Angioedema
What Do We Know About LDL-C?
Antithrombotics and PAD: A New Paradigm in Practice
Addressing Iron Deficiency in Chronic HF
Comparing Treatment Alternatives in Ankylosing Spondylitis
Treating HFrEF: Challenges Faced
Time to Take Gout Seriously
Expert Perspectives on Hyperkalemia for the Specialist
Efficacy and Safety of Edoxaban in Patients With AF and HF
Exploring Emerging Treatments for Hyperkalemia
PCSK9 Inhibitors and Cardiovascular Outcomes
At The Cutting Edge of Developments in the Management of Hyperkalemia
Deborah J. Clegg, PhD, Michael Cody, MD, Biff F. Palmer, MD 
The Importance of Getting the Dose Right in HF
Using Heart Rate as a Biomarker in Clinical Practice.
Volume 62, Issue 3, Pages (September 2002)
Multidisciplinary Management of Hyperkalemia:
Hyperkalemia in the Hospital
Overcoming Clinical Inertia
Shifting Currents in Hyperkalemia Management 2015 in Review
Shifting Currents in Hyperkalemia Management 2015 in Review
Challenging the Myths in Heart Failure With Reduced Ejection Fraction
The Road to Quality Improvement in HER2-Positive Breast Cancer
CAD and HF Often Coexist
Volume 90, Issue 3, Pages (September 2016)
Proteasome Inhibitors and Patients
Current Controversies and Advances in Hepatorenal Syndrome
Reducing Risk for CV Outcomes
Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Assessing the Burden of Hyperkalemia
New Paradigms in M0 CRPC.
Assessing the Burden of Hyperkalemia
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Uptitration of Medications in HF: Start Low but Aim High and Stay High
What's New in Oral Combination Therapy for Type 2 Diabetes?
Emerging Advances in Reducing Renal Complications of T2D
Lipids, the Heart, and the Kidney
Challenges and Emerging Solutions in Anemia Management Explored
Clinical Comparisons.
My PAH Patient.
Key Data on Improving Outcomes in HF Patients
RAASi Enabling in the Modern Era
Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.
Potassium Situations Resolved
Presentation transcript:

Breaking Down the Data in Hyperkalemia

Potassium Physiology

Definitions of Hyperkalemia Vary

Relationship Between Potassium Level and Patient Outcome

When to Address Hyperkalemia?

Major Causes of Hyperkalemia

Prevalence of Hyperkalemia

PARADIGM-HF Study Design

PARADIGM-HF Hyperkalemia Development During Study

Hyperkalemia in HF

Guideline Recommendations Regarding RAAS Inhibitor Use Based on Serum K+ Level

Impact of BP Control on Renal Disease Progression

Chronic Management of Hyperkalemia

SPS

Comparison of Patiromer and SZC*

Long-Term Efficacy of Potassium Binders

Studies Evaluating the Efficacy and Safety of SZC and Patiromer

Chronic Use of Potassium Binders Rebound Hyperkalemia

Teamwork in Managing Hyperkalemia

Abbreviations

Abbreviations (cont)